Collectively, our results show that IGF1, whose levels decline during HE, alleviates neuroinflammation and improves the pathological state of AOM-treated mice through the suppression of microglial activation and the regulation of neuron-microglia paracrine communication. The gene discussed is IGF1; the disease is hereditary elliptocytosis.